Jordy Mehawej1, Jane S Saczynski2, Catarina I Kiefe3, Hawa O Abu4, Mayra Tisminetzky3,5, Weijia Wang1, Benita A Bamgbade2, Eric Ding3, Darleen Lessard3, Edith Mensah Otabil1, Connor Saleeba1, Robert J Goldberg3, David D McManus1,3. 1. Division of Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts. 2. Department of Pharmacy and Health Systems Sciences, School of Pharmacy, Northeastern University, Boston, Massachusetts. 3. Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts. 4. Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts. 5. Division of Geriatrics, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
Abstract
STUDY OBJECTIVES: Geriatric impairments and obstructive sleep apnea (OSA) are prevalent among older patients with atrial fibrillation (AF). Little is known about the association between OSA and geriatric impairments, including frailty, cognitive performance, and AF-related quality of life. The objective of this study was to examine the associations of OSA with frailty, cognitive performance, and AF-related quality of life among older adults with AF. METHODS: Data from the Systemic Assessment of Geriatrics Elements-AF study were used, which included AF participants 65 years and older and with a CHA2DS2-VASc ≥ 2. The STOP-BANG questionnaire was used to assess the risk of OSA. Multivariable logistic regression models were used to examine the association between risk of OSA and geriatric impairments, adjusting for sociodemographic, geriatric, and clinical characteristics. RESULTS: A total of 970 participants (mean age 75 years; 51% male) were studied. Of the 680 participants without a medical history of OSA, 26% (n = 179) of participants had a low risk of OSA, 53% (n = 360) had an intermediate risk, and 21% (n = 141) had a high risk for OSA. Compared to those with low risk of OSA, participants with an intermediate or high risk of OSA were more likely to be frail (adjusted odds ratio = 1.67, 95% confidence interval: 1.08-2.56; adjusted odds ratio = 3.00, 95% confidence interval: 1.69-5.32, respectively) in the fully adjusted models. CONCLUSIONS: Our findings identify a group of patients at high risk who would benefit from early screening for OSA. Future longitudinal studies are needed to assess the effect of OSA treatment on frailty, physical functioning, and quality of life among patients with AF. CITATION: Mehawej J, Saczynski JS, Kiefe CI, et al. Association between risk of obstructive sleep apnea and cognitive performance, frailty, and quality of life among older adults with atrial fibrillation. J Clin Sleep Med. 2022;18(2):469-475.
STUDY OBJECTIVES: Geriatric impairments and obstructive sleep apnea (OSA) are prevalent among older patients with atrial fibrillation (AF). Little is known about the association between OSA and geriatric impairments, including frailty, cognitive performance, and AF-related quality of life. The objective of this study was to examine the associations of OSA with frailty, cognitive performance, and AF-related quality of life among older adults with AF. METHODS: Data from the Systemic Assessment of Geriatrics Elements-AF study were used, which included AF participants 65 years and older and with a CHA2DS2-VASc ≥ 2. The STOP-BANG questionnaire was used to assess the risk of OSA. Multivariable logistic regression models were used to examine the association between risk of OSA and geriatric impairments, adjusting for sociodemographic, geriatric, and clinical characteristics. RESULTS: A total of 970 participants (mean age 75 years; 51% male) were studied. Of the 680 participants without a medical history of OSA, 26% (n = 179) of participants had a low risk of OSA, 53% (n = 360) had an intermediate risk, and 21% (n = 141) had a high risk for OSA. Compared to those with low risk of OSA, participants with an intermediate or high risk of OSA were more likely to be frail (adjusted odds ratio = 1.67, 95% confidence interval: 1.08-2.56; adjusted odds ratio = 3.00, 95% confidence interval: 1.69-5.32, respectively) in the fully adjusted models. CONCLUSIONS: Our findings identify a group of patients at high risk who would benefit from early screening for OSA. Future longitudinal studies are needed to assess the effect of OSA treatment on frailty, physical functioning, and quality of life among patients with AF. CITATION: Mehawej J, Saczynski JS, Kiefe CI, et al. Association between risk of obstructive sleep apnea and cognitive performance, frailty, and quality of life among older adults with atrial fibrillation. J Clin Sleep Med. 2022;18(2):469-475.
Authors: Rodrigo P Pedrosa; Sandro G Lima; Luciano F Drager; Pedro R Genta; Aline C S Amaro; Murillo O Antunes; Edmundo Arteaga; Charles Mady; Geraldo Lorenzi-Filho Journal: Cardiology Date: 2010-12-08 Impact factor: 1.869
Authors: Eva M Schmitt; Edward R Marcantonio; David C Alsop; Richard N Jones; Selwyn O Rogers; Tamara G Fong; Eran Metzger; Sharon K Inouye Journal: J Am Med Dir Assoc Date: 2012-09-19 Impact factor: 4.669
Authors: Fredrik Holmqvist; Ni Guan; Zhaoyin Zhu; Peter R Kowey; Larry A Allen; Gregg C Fonarow; Elaine M Hylek; Kenneth W Mahaffey; James V Freeman; Paul Chang; DaJuanicia N Holmes; Eric D Peterson; Jonathan P Piccini; Bernard J Gersh Journal: Am Heart J Date: 2015-02-07 Impact factor: 4.749
Authors: John Spertus; Paul Dorian; Rosemary Bubien; Steve Lewis; Donna Godejohn; Matthew R Reynolds; Dhanunjaya R Lakkireddy; Alan P Wimmer; Anil Bhandari; Caroline Burk Journal: Circ Arrhythm Electrophysiol Date: 2010-12-15
Authors: Weijia Wang; Jane Saczynski; Darleen Lessard; Tanya Mailhot; Bruce Barton; Molly E Waring; Felix Sogade; Robert Hayward; Robert Helm; David D McManus Journal: J Cardiovasc Electrophysiol Date: 2019-09-25
Authors: Malini Madhavan; DaJuanicia N Holmes; Jonathan P Piccini; Jack E Ansell; Gregg C Fonarow; Elaine M Hylek; Peter R Kowey; Kenneth W Mahaffey; Laine Thomas; Eric D Peterson; Paul Chan; Larry A Allen; Bernard J Gersh Journal: Am Heart J Date: 2019-01-30 Impact factor: 4.749
Authors: Rebecca Gugganig; Stefanie Aeschbacher; Darryl P Leong; Pascal Meyre; Steffen Blum; Michael Coslovsky; Jürg H Beer; Giorgio Moschovitis; Dominic Müller; Daniela Anker; Nicolas Rodondi; Samuel Stempfel; Christian Mueller; Christine Meyer-Zürn; Michael Kühne; David Conen; Stefan Osswald Journal: Eur Heart J Qual Care Clin Outcomes Date: 2021-01-25